Senate Confirms Robert F. Kennedy Jr. as Trump’s Health Secretary
3 min read
The Senate on Thursday confirmed Robert F. Kennedy Jr. as the Secretary of Health and Human Services (HHS) in President Donald Trump’s cabinet, marking a significant and controversial appointment. The Republican-controlled Senate approved the nomination in a 52-48 vote, largely along party lines.
Kennedy, a 71-year-old environmental attorney and well-known vaccine skeptic, will oversee one of the federal government’s most critical agencies, responsible for public health, food safety, and medical research. His confirmation followed weeks of heated debates and contentious hearings, reflecting sharp divisions over his fitness for the role.
A Contentious Path to Confirmation
The confirmation process for Kennedy was marked by intense scrutiny of his controversial views and past actions. As the founder of Children’s Health Defense, a nonprofit that has frequently criticized vaccines and challenged public health policies, Kennedy faced pointed questions during back-to-back Senate hearings late last month.
Democrats, as well as some Republicans, highlighted Kennedy’s history of promoting debunked claims linking vaccines to autism and criticized his selective interpretation of scientific studies. His tenure at the organization and its lawsuits against federal agencies, including challenges to the authorization of COVID-19 vaccines for children, became central issues in the confirmation process.
Despite these controversies, Kennedy’s nomination advanced to the full Senate thanks to a key endorsement from Sen. Bill Cassidy (R-La.), chair of the Senate Committee on Health, Education, Labor, and Pensions (HELP). Initially critical of Kennedy’s past statements, Cassidy announced his support after securing significant commitments from Kennedy, including quarterly hearings, data transparency, and advance notice for any changes to vaccine safety policies.
Divided GOP Support
While most Republican senators rallied behind Kennedy, Sen. Mitch McConnell (R-Ky.), a childhood polio survivor and staunch advocate for vaccines, notably voted against the nomination. McConnell cited his strong belief in the importance of vaccines and public health science, breaking ranks with his party in a rare move.
Other key Republicans, including Sen. Susan Collins (R-Maine) and Sen. Lisa Murkowski (R-Alaska), expressed reservations but ultimately supported Kennedy after he promised to base vaccine recommendations on data-driven, evidence-based research. Murkowski acknowledged ongoing concerns but emphasized the nominee’s commitments to transparency and collaboration with Congress.
Shifting the Focus of Public Health
In his new role, Kennedy has pledged to prioritize chronic disease prevention and overhaul federal dietary guidelines to promote healthier lifestyles. His “Make America Healthy Again” campaign emphasizes addressing the root causes of chronic illnesses, such as ultra-processed foods and environmental toxins.
“Our country is not going to collapse because we get the marginal tax rate wrong,” Kennedy said during his hearings. “It is going to collapse if we fail to address this epidemic of chronic disease. And I am uniquely positioned to tackle this crisis.”
From Rival to Ally
Kennedy’s confirmation caps a remarkable political evolution. Initially launching a long-shot campaign for the Democratic presidential nomination in 2023, Kennedy later switched to an independent bid against President Joe Biden. During the campaign, he and Trump exchanged sharp criticisms, with Trump labeling Kennedy a “radical liberal” and Kennedy firing back at what he called “wild and inaccurate claims.”
However, in a surprising turn, Kennedy dropped his presidential bid in August 2024 and endorsed Trump, citing shared values and a desire to influence public health policy. Trump later praised Kennedy as “an incredible champion” and announced his intent to nominate him for the HHS position after winning reelection in November.
A Polarizing Appointment
Kennedy’s confirmation as HHS secretary has drawn mixed reactions across the political spectrum. Supporters applaud his commitment to challenging Big Pharma and reforming public health priorities, while critics warn that his history of vaccine skepticism could undermine confidence in public health programs.
The final vote on Kennedy’s nomination came just a day after another controversial Trump cabinet pick, former congresswoman Tulsi Gabbard, was confirmed as Director of National Intelligence in an equally narrow 52-48 vote.
As Kennedy assumes leadership of the Department of Health and Human Services, all eyes will be on how he navigates the agency’s vast responsibilities and whether he can bridge the deep divisions over public health policy that have defined his career.
About The Author
